EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis

Nina Suda iD, Gabrielle Page-Wilson, Jacqueline Lonier, Utpal B Pajvani iD

Journal of Diabetes Investigation · 2026

DOI: 10.1111/jdi.70239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Nina Suda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Naomi Berrie Diabetes Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Diabetic Ketoacidosis, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the discovery of insulin over a century ago, how we conceptualize, describe and treat diabetes has evolved, paving the way for the identification of distinct diabetes subgroups and individualized treatment options. Historically, the term ketosis‐prone diabetes (KPD) has comprised a group of diabetes syndromes characterized by severe pancreatic β‐cell dysfunction, but lacking the autoimmunity and irreversibility that underlies type 1 diabetes (T1D). Similarly, the defining feature of KPD—diabetic ketoacidosis—is uncharacteristic of type 2 diabetes (T2D). Initially, it was thought to be unique to Black populations, which led to early etiologic investigations narrowly focused on monogenic causes. However, it is now recognized that KPD occurs in diverse racial and ethnic groups and may be provoked by infection, leading to an expanded view of its pathogenesis. Here, we review these updated mechanistic views, highlight novel research tools being deployed to advance our understanding of KPD, and discuss implications of these data to inform our views on β‐cell biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsDiabetic KetoacidosisDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansAnimals

Stichwörter der Autor:innen

Atypical diabetesβ cell dysfunctionβ cell mass

Autor:innen und Institutionen

  • Naomi Berrie Diabetes Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Atria Health & Research Institute, New York, NY, USA.

ORCID-Profile: Nina Suda, Utpal B Pajvani

Zitieren

APA

Suda, N., Page-Wilson, G., Lonier, J., & Pajvani, U. B. (2026). Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70239

Vancouver

Suda N, Page-Wilson G, Lonier J, Pajvani UB. Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70239

BibTeX
@article{Suda2026,
  author = {Suda, Nina and Page-Wilson, Gabrielle and Lonier, Jacqueline and Pajvani, Utpal B},
  title = {Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  doi = {10.1111/jdi.70239}
}
Kostenlos starten →